Lung Cancer

Cancer Type:

General Lung Cancer, Non Small Cell Lung Cancer, Chemo Medication, Immunotherapies

Disease Learning:

ASCO 2018 - Keynote 158 - Keytruda in Previously Treated, Now Relapsing Patients with SCLC

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...

Cancer Journey:

Cancer Type:

General Lung Cancer, Immunotherapies, Small Cell Lung Cancer, Adjuvant Therapy

Disease Learning:

ASCO 2018 - Combining Metformin with Standard EGFR Therapy - Is the Jury Still Out

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...

Cancer Journey:

Cancer Type:

General Lung Cancer, Chemotherapy, Non Small Cell Lung Cancer, Targeted Therapies - EGFR

Disease Learning:

ASCO 2018 - Tarceva Combined with Carboplatin & Alimta - Given Upfront Will it Affect Pace of Disease?

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...

Cancer Journey:

Cancer Type:

General Lung Cancer, Non Small Cell Lung Cancer, Chemo Medication, Targeted Therapy, Adjuvant Therapy

Disease Learning:

ASCO 2018 - Tarceva or Tarceva with Avastin as 1st Line for EGFR Positive NSCLC vs. Tagrisso or Vizimpro

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...

Cancer Journey:

Cancer Type:

General Lung Cancer, Non Small Cell Lung Cancer, Targeted Therapies - EGFR, First-line treatment

Disease Learning:

Articles

Chance of Cure in Advanced Cancer: What do Older Patients Believe

At ASCO 2018, Dr. Melissa Loh presented a study titled: "Chance of Cure in Advanced Cancer: What Do Older Patients Believe and How Are These Beliefs Related to Their Preferences?". This study looked at patients and their beliefs regarding a cure for cancer, specifically in older patients with advanced cancer. Patients who are certain that they could be cured pose unique challenges for physicians and shows a need for clear communication between patients and their physicians regarding the outcome of treatment and quality of life.

Cancer Journey:

In Treatment, In Remission, Survivorship

Cancer Type:

Lung Cancer, Blood Cancers, Head and Neck Cancer, Other

Disease Learning:

General Lung Cancer, Aging and Elderly, Symptoms, General Blood Cancer, General Head and Neck Cancer, Other

JOIN GRACE - Live in Seattle, November 10, 2018 ~Local Therapies for Metastatic Lung Cancer

The Global Resource for Advancing Cancer Education (GRACE) in partnership with Swedish Cancer Institute presents: Local Therapies for...

Cancer Journey:

Cancer Type:

General Lung Cancer, Non Small Cell Lung Cancer

Disease Learning:

2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know

Download slides from LIVE WEBCAST of November 18, 2017 in partnership with Georgetown University Hospital, GRACE presents: 2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know

Cancer Journey:

Cancer Type:

Immunotherapies, Investigational Agents, Clinical Trials

Disease Learning:

Retrospective Data and Real World Evidence: The Poor Stepchild of Clinical Trials?

Many physicians worship evidence-based medicine, which is generally a very good practice that ensures that medical practice isn’t dictated by our...

Cancer Journey:

Cancer Type:

Lung Cancer, Blood Cancers, Head and Neck Cancer, Other

Disease Learning:

Clinical Trials

My Top 10 ASCO 2017 Lung Cancer Presentations

Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...

Cancer Journey:

Cancer Type:

Non Small Cell Lung Cancer, Small Cell Lung Cancer

Disease Learning:

Community Forum

Videos now posted! OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?

On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a live and webcast discussion on Local Therapies for...

Cancer Journey:

Cancer Type:

Lung Cancer, General Lung Cancer, Chemotherapy, 3rd Line and beyond, Scans - PET-CT, etc., Surgical, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer

Disease Learning:

Non-Small Cell Lung Cancer Patients and Caregivers -- opportunity to participate in a study for 'Rare Patient Voice'

Hi All - I was approached by a WhatNext Group partnered with Rare Patient Voice, with the opportunity to participate in a study specifically for Non-...

Cancer Journey:

Survivorship

Cancer Type:

Lung Cancer, General Lung Cancer

Disease Learning:

Adrenal metastasis from NSCLC

Greetings all, I'm a medical doctor from Vietnam. I want to discuss to you about my patient. He is 58 years old, he is hospitalize with chronic...

Cancer Journey:

Cancer Type:

Lung Cancer, Chemo Medication, Chemotherapy, First-line treatment

Disease Learning:

Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?

Hi Grace Members, Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who,...

Cancer Journey:

Cancer Type:

Lung Cancer, Drugs, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Procedures & Treatments, Chemotherapy, Tumor Marker Tests, Targeted Therapy, Investigational Agents, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer

Disease Learning:

Progression on Tarceva - T790m negative

Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.

Cancer Journey:

Cancer Type: